Tumor exploits alternative strategies to achieve vascularization
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Neoangiogenesis is crucial for solid tumor growth and invasion, as the vasculature provides metabolic support and access to the circulation. Current antiangiogenic therapies have been designed on the assumption that endothelial cells forming the tumor vasculature exhibit genetic stability. Recent studies demonstrate that this is not the case. Tumor endothelial cells possess a distinct phenotype, differing from normal endothelial cells at both molecular and functional levels. This challenges the concept that tumor angiogenesis exclusively depends on normal endothelial cell recruitment from the surrounding vascular network. Indeed, recent data suggest alternative strategies for tumor vascularization. It has been reported that tumor vessels may derive from an intratumor embryonic‐like vasculogenesis. This condition might be due to differentiation of normal stem and progenitor cells of hematopoietic origin or resident in tissues. Cancer stem cells may also participate in tumor vasculogenesis by virtue of their stem and progenitor cell properties. Finally, normal endothelial cells might be reprogrammed to a proangiogenic or dedifferentiated phenotype by genetic information transmitted from the tumor trough apoptotic bodies, or following mRNA and microRNA transfer by exosomes and microvesicles. In this review, we discuss the different aspects of intratumor angiogenesis and vasculogenesis, the known mechanisms involved, and the possible implications for the response to antiangiogenic therapy.—Bussolati, B., Grange, C., Camussi, G. Tumor exploits alternative strategies to achieve vascularization. FASEB J. 25, 2874–2882 (2011). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2006) · Leukemia · doi:10.1038/sj.leu.2404296 · Cited by 1,340
A tumorigenic subpopulation with stem cell properties in melanomas
Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280
Collino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., & Camussi, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011803 · Cited by 608 · cited 1×
“Moreover, MVs contain selected patterns of miRNA that can be transferred to target cells, inducing epigenetic changes in bystander cells (43, 44).”
BackgroundSelf-citationHorizontal transfer of oncogenes by uptake of apoptotic bodies
Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M. J., Spetz, A.-L., & Holmgren, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101129998 · Cited by 550
Ebos, J. M. L., Lee, C. R., & Kerbel, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0095 · Cited by 291
Wysoczynski, M., & Ratajczak, M. Z. (2009) · International Journal of Cancer · doi:10.1002/ijc.24479 · Cited by 216 · cited 1×
“Within the tumor environment, cell damage induced by hypoxia, chemotherapy, and irradiation may induce MV secretion by tumor cells and promote angiogenic pathways (47).”
Background
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Extracellular vesicles in physiological and pathological conditions
Yuana, Y., Sturk, A., & Nieuwland, R. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.002 · Cited by 569
“provide expanding tissues and organs with oxygen and nutrients, and concurrently remove the metabolic waste.(63)”
BackgroundDi Vizio, D., Morello, M., Dudley, A. C., Schow, P. W., Adam, R. M., Morley, S., Mulholland, D., Rotinen, M., Hager, M. H., Insabato, L., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.07.030 · Cited by 422
Exosomal Tumor MicroRNA Modulates Premetastatic Organ Cells
Rana, S., Malinowska, K., & Zöller, M. (2013) · Neoplasia · doi:10.1593/neo.122010 · Cited by 346
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Olejarz, W., Kubiak-Tomaszewska, G., Chrzanowska, A., & Lorenc, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165840 · Cited by 299
Host Matrix Modulation by Tumor Exosomes Promotes Motility and Invasiveness
Mu, W., Rana, S., & Zöller, M. (2013) · Neoplasia · doi:10.1593/neo.13786 · Cited by 248
“[6] Bussolati B, Grange C, and Camussi G (2011).”
BackgroundFiorio Pla, A., Ong, H. L., Cheng, K. T., Brossa, A., Bussolati, B., Lockwich, T., Paria, B., Munaron, L., & Ambudkar, I. S. (2012) · Oncogene · doi:10.1038/onc.2011.231 · Cited by 183
“However, their stability has been questioned with several studies showing that tumor-derived EC (TEC) differ significantly from their normal counterparts at genetic and functional levels (St Croix et al., 2000; Hida et al., 2004; Bussolati et al., 2011).”
Self-citationA review of mathematical models for the formation of vascular networks
Scianna, M., Bell, C. G., & Preziosi, L. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.04.037 · Cited by 167
“As well as exhibiting altered genotype, phenotype, and function, TECs are often aneuploid, display chromosomal instability, and express peculiar genes [46, 201, 243].”
BackgroundPolicastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
Metadata
- Authors
- Bussolati, B., Grange, C., & Camussi, G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2011-05-31
- Volume
- 25
- Issue
- 9
- Pages
- 2874-2882
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2145036915
- Cited by
- 94
- References
- 7
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.